2023-04-24 17:11:41 ET
- Medpace Holdings ( NASDAQ: MEDP ) is up 23% in after-hours trading after boosting its 2023 full-year guidance for both revenue and EPS.
- For the former, the company is now projecting $1.75B to $1.81B. The previous forecast was $1.69B to $1.75B. Consensus is $1.71B.
- For EPS, Medpace ( MEDP ) now sees full-year EPS of $7.81 to $8.40, compared to $7.53 to $8.14. Consensus estimate is $8.12.
- In Q1, revenue rose 31% compared to the prior-year period, while GAAP EPS of $2.27 beat by $0.46 .
For further details see:
Medpace up 23% post market on 2023 revenue, EPS guidance increase